BAP1 as a guardian of genome stability: implications in human cancer
Abstract BAP1 is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase with a wide array of biological activities. Studies in which advanced sequencing technologies were used have uncovered a link between BAP1 and human cancer. Somatic and germline mutations of the BAP1 gene have been id...
Main Authors: | Jongbum Kwon, Daye Lee, Shin-Ai Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-04-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-023-00979-1 |
Similar Items
-
Targeting BAP1 with small compound inhibitor for colon cancer treatment
by: Minhwa Kang, et al.
Published: (2023-02-01) -
BAP1 in cancer: epigenetic stability and genome integrity
by: Sabrina Caporali, et al.
Published: (2022-11-01) -
MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer
by: Natsumi Tsuboyama, et al.
Published: (2022-09-01) -
Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer
by: Bodo C. Melnik
Published: (2017-08-01) -
BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN
by: Rong Deng, et al.
Published: (2021-01-01)